Craft

Merck

Stock Price

$103.7

2024-10-29

Market Capitalization

$294.7 B

2024-08-26

Revenue

$65 B

FY, 2025

Merck Summary

Company Summary

Overview
Merck (also known as MSD) is a company that develops and manufactures medicines and vaccines for human and animal health. It provides pharmaceuticals for oncology, infectious diseases, cardiovascular disease, immunology, neuroscience, ophthalmology, and animal health, as well as vaccines. The company supplies products to healthcare professionals, hospitals, research institutions, and veterinary providers.
Type
Public
Status
Active
Founded
1891
HQ
Rahway, NJ, US | view all locations
Website
https://www.merck.com
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Robert M. Davis

    Robert M. Davis, Chairman and Chief Executive Officer

  • Carmen La Rosa

    Carmen La Rosa, Executive Director, Clinical Research

  • Sanat Chattopadhyay

    Sanat Chattopadhyay, Executive Vice President and President, Merck Manufacturing Division

  • Richard R. DeLuca, Jr.

    Richard R. DeLuca, Jr., Executive Vice President and President, Merck Animal Health

Operating MetricsView all

Patent Portfolios

22
12.0%

FY, 2022

Phase III Drug Candidate

9
12.5%

FY, 2022

Phase III Trials Products

32
14.3%

FY, 2022

LocationsView all

197 locations detected

  • Rahway, NJ HQ

    United States

    126 East Lincoln Avenue

  • Alpharetta, GA

    United States

    11605 Haynes Bridge Rd #300

  • Boston, MA

    United States

    33 Avenue Louis Pasteur

  • Durham, NC

    United States

    5325 Old Oxford Rd

  • Elkton, VA

    United States

    2778 S E Side Hwy

  • Madison, NJ

    United States

    2 Giralda Farms

and 191 others

Merck Financials

Summary Financials

Revenue (Q1, 2026)
$16.3B
Gross profit (Q1, 2026)
$12.1B
Net income (Q1, 2026)
($4.2B)
Cash (Q1, 2026)
$5.3B
Enterprise value
$338.5B

Footer menu